Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Information Dissemination | 15 | 2024 | 268 | 5.220 |
Why?
|
| Informed Consent | 9 | 2024 | 415 | 1.880 |
Why?
|
| Bioethics | 6 | 2020 | 71 | 1.580 |
Why?
|
| Disabled Persons | 3 | 2020 | 109 | 1.500 |
Why?
|
| Databases, Genetic | 3 | 2019 | 757 | 1.440 |
Why?
|
| Confidentiality | 5 | 2019 | 118 | 1.230 |
Why?
|
| Public Policy | 6 | 2016 | 55 | 1.180 |
Why?
|
| Medical Informatics | 5 | 2019 | 152 | 1.130 |
Why?
|
| Genetic Testing | 8 | 2024 | 1696 | 1.020 |
Why?
|
| Direct-To-Consumer Screening and Testing | 2 | 2022 | 14 | 0.920 |
Why?
|
| Privacy | 2 | 2021 | 28 | 0.890 |
Why?
|
| Stakeholder Participation | 3 | 2019 | 42 | 0.840 |
Why?
|
| Health Equity | 1 | 2024 | 59 | 0.840 |
Why?
|
| Embryo Research | 4 | 2009 | 9 | 0.810 |
Why?
|
| Genetic Research | 2 | 2019 | 66 | 0.760 |
Why?
|
| Computer Security | 2 | 2018 | 30 | 0.760 |
Why?
|
| Genetic Privacy | 2 | 2018 | 44 | 0.750 |
Why?
|
| Ethics Consultation | 4 | 2016 | 36 | 0.750 |
Why?
|
| Genetics | 1 | 2020 | 28 | 0.710 |
Why?
|
| Patents as Topic | 2 | 2017 | 27 | 0.710 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 364 | 0.700 |
Why?
|
| Mentoring | 1 | 2022 | 105 | 0.690 |
Why?
|
| Scholarly Communication | 1 | 2020 | 19 | 0.690 |
Why?
|
| Ethics, Clinical | 2 | 2022 | 83 | 0.690 |
Why?
|
| Mentors | 1 | 2022 | 210 | 0.670 |
Why?
|
| Personally Identifiable Information | 1 | 2018 | 1 | 0.640 |
Why?
|
| Biomedical Technology | 1 | 2019 | 39 | 0.640 |
Why?
|
| Biomedical Research | 4 | 2019 | 801 | 0.630 |
Why?
|
| Embryonic Stem Cells | 3 | 2009 | 278 | 0.630 |
Why?
|
| Databases, Nucleic Acid | 1 | 2019 | 116 | 0.620 |
Why?
|
| Schools | 1 | 2019 | 237 | 0.590 |
Why?
|
| Ethicists | 4 | 2022 | 43 | 0.590 |
Why?
|
| Mental Health | 1 | 2021 | 416 | 0.580 |
Why?
|
| Parents | 4 | 2024 | 1082 | 0.580 |
Why?
|
| Public Health | 1 | 2019 | 296 | 0.570 |
Why?
|
| Health Policy | 2 | 2019 | 278 | 0.560 |
Why?
|
| Homocysteine | 1 | 2017 | 148 | 0.560 |
Why?
|
| Autistic Disorder | 1 | 2020 | 354 | 0.560 |
Why?
|
| Federal Government | 1 | 2016 | 18 | 0.530 |
Why?
|
| Public Opinion | 1 | 2016 | 77 | 0.530 |
Why?
|
| Genotype | 1 | 2024 | 4252 | 0.530 |
Why?
|
| Minors | 1 | 2015 | 7 | 0.530 |
Why?
|
| Clinical Medicine | 1 | 2016 | 26 | 0.520 |
Why?
|
| Parental Consent | 1 | 2015 | 26 | 0.510 |
Why?
|
| Patients | 3 | 2018 | 246 | 0.510 |
Why?
|
| Internationality | 1 | 2016 | 205 | 0.510 |
Why?
|
| United States | 19 | 2021 | 15861 | 0.500 |
Why?
|
| Research Subjects | 1 | 2015 | 64 | 0.500 |
Why?
|
| Physician-Patient Relations | 3 | 2024 | 736 | 0.500 |
Why?
|
| Moral Obligations | 2 | 2013 | 85 | 0.490 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 323 | 0.480 |
Why?
|
| Physician's Role | 2 | 2024 | 230 | 0.480 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2009 | 197 | 0.480 |
Why?
|
| Communication | 3 | 2018 | 839 | 0.470 |
Why?
|
| Advisory Committees | 4 | 2009 | 196 | 0.460 |
Why?
|
| Humans | 59 | 2024 | 270740 | 0.450 |
Why?
|
| Vaccination | 1 | 2019 | 1166 | 0.430 |
Why?
|
| Health Care Rationing | 1 | 2014 | 80 | 0.430 |
Why?
|
| Disclosure | 4 | 2024 | 180 | 0.430 |
Why?
|
| Decision Making | 4 | 2024 | 1252 | 0.430 |
Why?
|
| Quality Improvement | 1 | 2020 | 914 | 0.420 |
Why?
|
| Internship and Residency | 1 | 2024 | 1452 | 0.420 |
Why?
|
| Blood Glucose | 1 | 2017 | 1269 | 0.420 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 625 | 0.410 |
Why?
|
| Fear | 1 | 2014 | 253 | 0.410 |
Why?
|
| Policy Making | 2 | 2019 | 76 | 0.410 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 700 | 0.410 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1655 | 0.400 |
Why?
|
| Truth Disclosure | 1 | 2014 | 179 | 0.400 |
Why?
|
| Ventricular Function | 1 | 2013 | 100 | 0.400 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2012 | 9 | 0.400 |
Why?
|
| Treatment Refusal | 1 | 2013 | 128 | 0.400 |
Why?
|
| Fetal Viability | 1 | 2012 | 31 | 0.390 |
Why?
|
| Preimplantation Diagnosis | 1 | 2012 | 37 | 0.390 |
Why?
|
| Neurosciences | 2 | 2024 | 55 | 0.390 |
Why?
|
| Continuity of Patient Care | 1 | 2014 | 206 | 0.390 |
Why?
|
| Pandemics | 1 | 2020 | 1610 | 0.370 |
Why?
|
| Guidelines as Topic | 2 | 2009 | 361 | 0.360 |
Why?
|
| Fertilization in Vitro | 1 | 2012 | 207 | 0.350 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 2359 | 0.350 |
Why?
|
| Information Technology | 2 | 2019 | 9 | 0.330 |
Why?
|
| Government Regulation | 1 | 2009 | 58 | 0.330 |
Why?
|
| Genomics | 7 | 2024 | 2835 | 0.320 |
Why?
|
| Chimera | 1 | 2009 | 152 | 0.320 |
Why?
|
| Oncologists | 2 | 2023 | 136 | 0.320 |
Why?
|
| Community Participation | 2 | 2019 | 54 | 0.320 |
Why?
|
| Patient Discharge | 1 | 2014 | 698 | 0.310 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 101 | 0.310 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 2573 | 0.310 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 602 | 0.290 |
Why?
|
| Ethical Analysis | 2 | 2019 | 53 | 0.290 |
Why?
|
| Heart-Assist Devices | 2 | 2013 | 1042 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 1412 | 0.280 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2014 | 927 | 0.280 |
Why?
|
| Policy | 2 | 2024 | 52 | 0.270 |
Why?
|
| Patient Participation | 4 | 2023 | 453 | 0.270 |
Why?
|
| Autopsy | 2 | 2016 | 170 | 0.260 |
Why?
|
| Algorithms | 1 | 2017 | 3891 | 0.260 |
Why?
|
| Bioethical Issues | 1 | 2005 | 21 | 0.260 |
Why?
|
| Ethics, Medical | 4 | 2016 | 436 | 0.260 |
Why?
|
| Embryo, Mammalian | 2 | 2009 | 746 | 0.260 |
Why?
|
| Physicians | 2 | 2018 | 854 | 0.260 |
Why?
|
| Cybernetics | 1 | 2005 | 1 | 0.250 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 3844 | 0.250 |
Why?
|
| Patient Selection | 1 | 2013 | 2025 | 0.250 |
Why?
|
| Embryo Disposition | 1 | 2005 | 5 | 0.250 |
Why?
|
| Legislation, Medical | 1 | 2005 | 13 | 0.250 |
Why?
|
| Adoption | 1 | 2005 | 16 | 0.250 |
Why?
|
| Hospitals, Voluntary | 1 | 2004 | 4 | 0.240 |
Why?
|
| Managed Care Programs | 1 | 2005 | 83 | 0.240 |
Why?
|
| Expert Testimony | 1 | 2005 | 55 | 0.240 |
Why?
|
| Embryo Transfer | 1 | 2005 | 89 | 0.230 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2024 | 7 | 0.230 |
Why?
|
| Biological Specimen Banks | 1 | 2005 | 75 | 0.230 |
Why?
|
| Professional Role | 1 | 2005 | 76 | 0.230 |
Why?
|
| Insurance Benefits | 1 | 2004 | 6 | 0.230 |
Why?
|
| Goals | 1 | 2005 | 187 | 0.230 |
Why?
|
| Ecosystem | 1 | 2024 | 118 | 0.230 |
Why?
|
| Neurophysiology | 1 | 2023 | 22 | 0.220 |
Why?
|
| Medically Uninsured | 1 | 2004 | 106 | 0.220 |
Why?
|
| HIV Infections | 1 | 2015 | 2154 | 0.220 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2022 | 20 | 0.210 |
Why?
|
| Hospital Costs | 1 | 2004 | 244 | 0.210 |
Why?
|
| Health Insurance Portability and Accountability Act | 2 | 2017 | 22 | 0.210 |
Why?
|
| Stem Cells | 1 | 2009 | 1216 | 0.200 |
Why?
|
| Bangladesh | 2 | 2022 | 22 | 0.200 |
Why?
|
| Terminology as Topic | 1 | 2005 | 418 | 0.200 |
Why?
|
| Insurance, Health | 1 | 2004 | 261 | 0.190 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2021 | 13 | 0.190 |
Why?
|
| Insurance Coverage | 1 | 2004 | 275 | 0.190 |
Why?
|
| General Surgery | 1 | 2024 | 333 | 0.190 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 140 | 0.180 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 676 | 0.180 |
Why?
|
| Genetic Counseling | 2 | 2022 | 417 | 0.170 |
Why?
|
| Coroners and Medical Examiners | 2 | 2016 | 17 | 0.170 |
Why?
|
| Ownership | 1 | 2019 | 40 | 0.170 |
Why?
|
| Heart Failure | 1 | 2013 | 2330 | 0.170 |
Why?
|
| RNA | 1 | 2024 | 1063 | 0.170 |
Why?
|
| Neoplasms | 5 | 2024 | 15927 | 0.160 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 705 | 0.150 |
Why?
|
| Surgeons | 1 | 2024 | 491 | 0.150 |
Why?
|
| Military Personnel | 1 | 2020 | 233 | 0.150 |
Why?
|
| Ethics Committees, Clinical | 2 | 2016 | 17 | 0.150 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 411 | 0.150 |
Why?
|
| Hospital Administrators | 1 | 2016 | 8 | 0.130 |
Why?
|
| State Government | 1 | 2015 | 33 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 514 | 0.120 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 322 | 0.120 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2015 | 105 | 0.120 |
Why?
|
| Genes, BRCA1 | 1 | 2017 | 397 | 0.120 |
Why?
|
| Politics | 2 | 2005 | 71 | 0.120 |
Why?
|
| Professional Competence | 2 | 2014 | 139 | 0.120 |
Why?
|
| Cadaver | 2 | 2016 | 202 | 0.120 |
Why?
|
| Chemoprevention | 1 | 2015 | 251 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 751 | 0.120 |
Why?
|
| Licensure | 1 | 2014 | 14 | 0.120 |
Why?
|
| Exome | 1 | 2018 | 1248 | 0.110 |
Why?
|
| Certification | 1 | 2014 | 107 | 0.110 |
Why?
|
| Writing | 1 | 2014 | 104 | 0.100 |
Why?
|
| Orbital Neoplasms | 1 | 2014 | 234 | 0.100 |
Why?
|
| Forecasting | 2 | 2019 | 702 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 5776 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 4492 | 0.100 |
Why?
|
| Attitude of Health Personnel | 2 | 2020 | 901 | 0.100 |
Why?
|
| Rhabdomyosarcoma | 1 | 2014 | 342 | 0.090 |
Why?
|
| Shock, Cardiogenic | 1 | 2013 | 193 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2024 | 1235 | 0.090 |
Why?
|
| Clinical Decision-Making | 1 | 2014 | 533 | 0.090 |
Why?
|
| Brain | 1 | 2023 | 4208 | 0.090 |
Why?
|
| Research Embryo Creation | 1 | 2009 | 1 | 0.090 |
Why?
|
| Female | 9 | 2024 | 148940 | 0.080 |
Why?
|
| Financing, Government | 1 | 2009 | 37 | 0.080 |
Why?
|
| Radiation Oncology | 1 | 2014 | 558 | 0.080 |
Why?
|
| Ethics Committees, Research | 1 | 2009 | 41 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2013 | 681 | 0.080 |
Why?
|
| Ethics, Research | 1 | 2009 | 67 | 0.080 |
Why?
|
| Research Support as Topic | 1 | 2009 | 120 | 0.080 |
Why?
|
| Adolescent | 5 | 2024 | 32767 | 0.080 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 831 | 0.080 |
Why?
|
| Radiotherapy | 1 | 2014 | 1857 | 0.070 |
Why?
|
| Social Responsibility | 2 | 2019 | 92 | 0.070 |
Why?
|
| Tissue and Organ Procurement | 1 | 2009 | 244 | 0.070 |
Why?
|
| Committee Membership | 1 | 2005 | 4 | 0.070 |
Why?
|
| Dissent and Disputes | 1 | 2005 | 40 | 0.060 |
Why?
|
| Male | 8 | 2024 | 128315 | 0.060 |
Why?
|
| Publications | 1 | 2005 | 54 | 0.060 |
Why?
|
| Biotechnology | 1 | 2005 | 77 | 0.060 |
Why?
|
| Contract Services | 1 | 2005 | 8 | 0.060 |
Why?
|
| Lawyers | 1 | 2005 | 5 | 0.060 |
Why?
|
| Ethics, Institutional | 1 | 2005 | 14 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 5923 | 0.060 |
Why?
|
| Risk Factors | 2 | 2022 | 17888 | 0.060 |
Why?
|
| Fees and Charges | 1 | 2004 | 13 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2009 | 821 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2005 | 151 | 0.060 |
Why?
|
| Infant | 2 | 2016 | 13999 | 0.060 |
Why?
|
| Prejudice | 1 | 2004 | 52 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2005 | 208 | 0.060 |
Why?
|
| Social Justice | 1 | 2004 | 56 | 0.060 |
Why?
|
| Atrophy | 1 | 2024 | 271 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2004 | 236 | 0.050 |
Why?
|
| Research Personnel | 1 | 2024 | 167 | 0.050 |
Why?
|
| Research | 1 | 2005 | 427 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1418 | 0.050 |
Why?
|
| Adult | 7 | 2024 | 82040 | 0.050 |
Why?
|
| Phosphates | 1 | 2022 | 178 | 0.050 |
Why?
|
| Serum Albumin | 1 | 2022 | 246 | 0.050 |
Why?
|
| Parathyroid Hormone | 1 | 2022 | 184 | 0.050 |
Why?
|
| Exploratory Behavior | 1 | 2022 | 103 | 0.050 |
Why?
|
| Quality of Life | 2 | 2013 | 4761 | 0.050 |
Why?
|
| DNA | 1 | 2010 | 3050 | 0.050 |
Why?
|
| Cell Line | 1 | 2009 | 5338 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 4795 | 0.050 |
Why?
|
| Texas | 2 | 2024 | 6449 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 529 | 0.040 |
Why?
|
| Intellectual Property | 1 | 2019 | 11 | 0.040 |
Why?
|
| Child | 4 | 2024 | 30559 | 0.040 |
Why?
|
| Family | 1 | 2024 | 783 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2004 | 964 | 0.040 |
Why?
|
| North Carolina | 1 | 2019 | 82 | 0.040 |
Why?
|
| Young Adult | 3 | 2024 | 22251 | 0.040 |
Why?
|
| California | 1 | 2019 | 212 | 0.040 |
Why?
|
| Pregnancy | 1 | 2012 | 8130 | 0.040 |
Why?
|
| Attitude | 1 | 2019 | 162 | 0.040 |
Why?
|
| Trust | 1 | 2019 | 109 | 0.040 |
Why?
|
| Information Services | 1 | 2017 | 42 | 0.040 |
Why?
|
| Professional-Family Relations | 1 | 2018 | 131 | 0.040 |
Why?
|
| Pedigree | 1 | 2022 | 2042 | 0.040 |
Why?
|
| Consent Forms | 1 | 2016 | 27 | 0.030 |
Why?
|
| Calcium | 1 | 2022 | 1578 | 0.030 |
Why?
|
| Health Facility Merger | 1 | 2015 | 9 | 0.030 |
Why?
|
| Death | 1 | 2016 | 130 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2016 | 115 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2015 | 69 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 3404 | 0.030 |
Why?
|
| North America | 1 | 2014 | 338 | 0.030 |
Why?
|
| Health Status | 1 | 2017 | 631 | 0.030 |
Why?
|
| Social Media | 1 | 2017 | 208 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 16215 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2013 | 245 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 33737 | 0.020 |
Why?
|
| Middle Aged | 4 | 2019 | 90352 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2018 | 1465 | 0.020 |
Why?
|
| Consultants | 1 | 2005 | 15 | 0.020 |
Why?
|
| Hospital Administration | 1 | 2005 | 25 | 0.020 |
Why?
|
| Conflict of Interest | 1 | 2005 | 92 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 8699 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 6764 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2016 | 17061 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 73333 | 0.010 |
Why?
|